Presentation is loading. Please wait.

Presentation is loading. Please wait.

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Published byHanne Torp Modified over 6 years ago

Similar presentations

Presentation on theme: "Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel."— Presentation transcript:

1 Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort 
Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel Cosmus Pyndt Diederichsen, MD, PhD, Susanne Hosbond, MD, Torben Bjerregaard Larsen, MD, PhD, Henrik Schmidt, MD, DMSc, Oke Gerke, MSc, PhD, Jesper Hallas, MD, DMSc, Kristian Thygesen, MD, DMSc, Hans Mickley, MD, DMSc  The American Journal of Medicine  Volume 127, Issue 4, Pages (April 2014) DOI: /j.amjmed Copyright © 2014 Elsevier Inc. Terms and Conditions

2 Figure 1 Flow diagram illustrating patient inclusion. cTnI = cardiac troponin I. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2014 Elsevier Inc. Terms and Conditions

3 Figure 2 Kaplan-Meier survival curves according to classification of myocardial infarction in type 1 and type 2. MI = myocardial infarction. The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2014 Elsevier Inc. Terms and Conditions

4 Figure 3 Association between triggering conditions and mortality in patients with type 2 myocardial infarction. In 14 of 119 patients, more than 1 triggering condition was identified (2 in 12 patients and 3 in 2 patients). The American Journal of Medicine  , DOI: ( /j.amjmed ) Copyright © 2014 Elsevier Inc. Terms and Conditions

Download ppt "Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel."

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
The Epidemic of the 20th Century: Coronary Heart Disease

The Epidemic of the 20th Century: Coronary Heart Disease
Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,

Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,
Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.

Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.
The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest  Anders Morten Grejs, MD, Jakob.

The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest  Anders Morten Grejs, MD, Jakob.
Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO 
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?  Susanne Elisabeth Hosbond,

Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?  Susanne Elisabeth Hosbond,
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.

Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.
Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice  Nikolaj Jangaard, MD, Laura Sarkisian, MD, Lotte.

Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice  Nikolaj Jangaard, MD, Laura Sarkisian, MD, Lotte.
Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 

Heather C. Brod, MA, Stanley Lemeshow, PhD, Philip F. Binkley, MD, MPH 
Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C

Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction

Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction
Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study  Torben Bjerregaard Larsen, MD,
Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G
Sleep Apnea and Risk of Deep Vein Thrombosis: A Non-randomized, Pair-matched Cohort Study  Kun-Ta Chou, MD, Chin-Chou Huang, MD, Yuh-Min Chen, MD, PhD,

Sleep Apnea and Risk of Deep Vein Thrombosis: A Non-randomized, Pair-matched Cohort Study  Kun-Ta Chou, MD, Chin-Chou Huang, MD, Yuh-Min Chen, MD, PhD,
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Predicting Survival in Oldest Old People

Predicting Survival in Oldest Old People
Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Similar presentations

Ads by Google